Qualcomm & Aramco Digital Launch AI 5G Industrial Smartphones - TECHx Media Qualcomm & Aramco Digital Launch AI 5G Industrial Smartphones
Qualcomm & Aramco Digital Launch AI 5G Industrial Smartphones
At LEAP 2025, Qualcomm Technologies, Inc. and Aramco Digital, the technology subsidiary of Aramco, announced a groundbreaking collaboration to develop the world's first AI-enabled industrial 5G smartphones with native support for the 450MHz spectrum. This innovation will power the next generation of AI-driven industrial applications, enhancing connectivity, efficiency, and operational intelligence. The new industrial smartphones will be equipped with Qualcomm® QCM8550 and QCM6490 processors, ensuring seamless 5G communication on the 450MHz spectrum for industrial IoT devices and edge computing applications.
'At Aramco Digital, we are committed to pushing the boundaries of technological innovation. This collaboration with Qualcomm Technologies, introducing the world's first AI-enabled industrial smartphone with 450MHz support, marks a significant milestone in our journey to empower industries with next-generation connectivity. By leveraging cutting-edge 5G and AI technologies, we are enabling smarter, more sustainable industries that align with the Kingdom's Vision 2030, driving industrial transformation globally,' said Eid Alharbi, Connectivity President, Aramco Digital.
Nakul Duggal, Group General Manager, Automotive, Industrial & Embedded IoT, and Cloud Computing at Qualcomm Technologies, Inc., emphasized the transformative impact of this collaboration. 'The industrial sector is evolving rapidly with advanced technologies, and our industrial smartphones with native support for 450MHz are another vital component in enabling industries to become more connected, efficient, safe, and sustainable. Qualcomm Technologies is proud to collaborate with Aramco Digital to support Saudi Arabia's industrial transformation in alignment with Vision 2030. This collaboration also accelerates technological advancements in the Middle East, delivering global benefits.'
Qualcomm Technologies and Aramco Digital previously introduced Aramco's first generative AI industrial IoT solutions, enhancing safety, efficiency, and sustainability across Aramco sites. The new industrial smartphones will further empower Aramco users by enabling seamless connectivity to these advanced applications, revolutionizing industrial operations. Attendees at LEAP 2025 can explore live demonstrations of the industrial smartphones and Qualcomm Technologies' 450MHz processors at Aramco Digital's stand, showcasing the future of AI-enabled industrial connectivity.
Qualcomm Technologies, Inc. is a global leader in wireless technology innovation, driving advancements in AI, 5G, and edge computing solutions across various industries. Aramco Digital is the technology arm of Aramco, dedicated to driving digital transformation and industrial innovation through AI, IoT, and next-generation connectivity solutions. For more updates on LEAP 2025 and groundbreaking tech innovations, stay tuned.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Arabian Business
an hour ago
- Arabian Business
Saudi Arabia Ministry of Hajj and Umrah announces start of new Umrah season
The Ministry of Hajj and Umrah has officially announced the commencement of the Umrah season for 2025 (1447 of the Islamic calendar), beginning on Tuesday with the opening of visa applications for international pilgrims. As part of its ongoing mission aligned with Saudi Vision 2030, the ministry aims to streamline and enrich the Umrah experience. Welcome, Guests of Allah 🕋🇸🇦 The 1447H Umrah season officially begins today with the issuance of visas for pilgrims arriving from outside Saudi Arabia. Starting tomorrow, Umrah permits will be available through the #Nusuk app. #Ease_And_Tranquility — Ministry of Hajj and Umrah (@MoHU_En) June 10, 2025 Starting Wednesday, pilgrims from abroad can secure their permits via the 'Nu s uk' app, Saudi Arabia's centralised digital gateway for Hajj and Umrah services. The platform simplifies the process of permit acquisition and offers a suite of digital tools designed to support and guide pilgrims throughout their journey. The ministry affirmed that extensive operational and technical preparations were made in advance, in coordination with relevant authorities, to ensure a smooth and efficient start to the season. As part of its broader vision, the ministry is also expanding multilingual digital tools and awareness initiatives to better serve pilgrims. These efforts are designed to maintain exceptional standards of care and security, underscoring the Kingdom's dedication to those making the sacred journey to Makkah and Madinah.
TECHx
3 hours ago
- TECHx
AmiViz Ranked Among Top Tech Workplaces in GCC
Home » Tech Value Chain » Distributors » AmiViz Ranked Among Top Tech Workplaces in GCC AmiViz, a cybersecurity-focused value-added distributor based in the Middle East, has been ranked 22nd on the 2025 list of Best Workplaces in Technology in the GCC region. The ranking was announced by Great Place to Work®, a global authority on workplace culture. This recognition highlights AmiViz's strong commitment to creating an inclusive, empowering, and innovation-driven work environment. It reflects the company's efforts to foster a culture where trust, collaboration, and professional growth are a priority. According to Great Place to Work®, the ranking is based on employee feedback collected through confidential surveys. It also includes an in-depth assessment of the company's HR practices, leadership involvement, and focus on employee well-being. AmiViz stood out for promoting a transparent and agile workplace. The company was recognized for encouraging employees to excel and contribute meaningfully to its mission. The company reported that its people-centric approach remains a core value. It continues to invest in employee development and well-being while navigating a rapidly evolving tech landscape. AmiViz promotes continuous learning and upskilling The company values diversity and encourages innovation Ilyas Mohammed, Chief Operating Officer at AmiViz, expressed pride in the achievement. He stated, 'Being recognized among the top workplaces in technology across the GCC is an honour that validates our belief that a strong company culture is a catalyst for sustainable growth. Our team is at the heart of everything we do, and this recognition is a reflection of their passion, dedication, and the values we live by every day.' The company revealed that this recognition comes during a phase of strategic expansion. It also highlights AmiViz's ability to scale while maintaining its core values. AmiViz continues to strengthen its position in cybersecurity distribution across the region. The company emphasized that its workplace culture plays a key role in this success. This announcement sends a clear message to employees, partners, and stakeholders. AmiViz is not only a leader in cybersecurity solutions but also a company that values its people as its greatest asset.
Arabian Post
6 hours ago
- Arabian Post
MediLink Therapeutics Taps Major Banks for Hong Kong Float
MediLink Therapeutics Ltd. is preparing to launch an initial public offering in Hong Kong, having secured China International Capital Corp., JPMorgan Chase & Co. and Morgan Stanley as its lead advisers, according to people with knowledge of the matter. The move comes as the clinical-stage biotech firm seeks to capitalise on growing investor interest in advanced tumour-targeting therapies and consolidate its platform of antibody‑drug conjugates. Founded in 2020 and headquartered in Suzhou with R&D operations in Shanghai and Boston, MediLink has developed a proprietary ADC technology known as TMALIN®. The platform facilitates precise delivery of cytotoxic agents to tumour cells, with the intention of widening therapeutic windows for solid tumour treatments. Its pipeline includes programs that have advanced to clinical stages in both China and the United States, supported by a Series B financing round of approximately USD 70 million in 2022. MediLink's strategic engagement of three underwriters reflects heightened confidence in anchor investors and broader syndication. China International Capital Corp. brings deep roots in Chinese capital markets and extensive IPO experience in the biotech sector. JPMorgan and Morgan Stanley add global banking heft and access to international investors. ADVERTISEMENT CICC itself is emerging as a top-tier sponsor for Hong Kong listings. It led or co-led 19 IPOs for Chinese corporates last year, raising USD 3.84 billion, positioning it as a dominant force amid market revival. The engagement of internationally renowned banks alongside CICC is likely aimed at boosting MediLink's valuation and widening investor interest both locally and abroad. While IPO details remain confidential, analysts suggest MediLink could seek a valuation in the mid‑to‑high hundreds of millions of dollars. That would reflect both the advanced stage of its pipeline and prevailing market multiples for ADC developers. Comparable biotech flotations in Hong Kong and the U.S. have reflected growing appetite for oncology-focused platforms. Alongside listing ambitions, MediLink continues to advance its clinical and licensing goals. In March it unveiled preclinical data at the American Association for Cancer Research annual meeting; earlier in the year it received FDA clearance for its IND application for YL217, its lead candidate. YL201, another programme, received Breakthrough Therapy Designation in January for treatment of recurrent/metastatic nasopharyngeal carcinoma. The company has also pursued strategic licensing agreements with global pharmaceutical firms to expand development and commercialisation capabilities. A licensing deal under discussion ahead of the IPO is believed aimed at enhancing distribution reach while reinforcing MediLink's balance sheet. The IPO effort is part of a broader resurgence in biotech listings in Hong Kong, where authorities have eased regulations to attract innovation-driven offerings. CICC and other banks have ramped up support for ADC and gene therapy companies, signalling a turning point after a lull in listings. ADVERTISEMENT MediLink's choice of banks aligns with a wider trend: CICC has co-sponsored blockbuster floats including the forthcoming mega‑IPO of CATL, while banks like Goldman Sachs and Morgan Stanley have also participated. In this context, MediLink is positioning itself to tap both deep domestic networks and international capital. Stakeholder sentiment appears optimistic. MediLink's management team, comprised of co‑founders Tony Xue and Jiaqiang Cai alongside C‑suite leaders experienced in drug development and financial strategy, has overseen steady progress in its ADC pipeline and established global partnerships. Jason Li's appointment as CFO in 2023 reportedly strengthened the company's capital market readiness. Market observers highlight challenges ahead. ADC development remains capital-intensive, clinical risks high, and competition fierce among domestic and international peers. Success will hinge on late‑stage data and licensing traction. At the same time, geopolitical tensions and volatility in Hong Kong equity markets may affect investor sentiment. MediLink must also navigate post‑IPO obligations, including regulatory reporting and corporate governance under Hong Kong's Main Board requirements. Mitigating execution risk will be critical, underscoring the role of its chosen bankers in underwriting diligence and market support. Analysts describe the listing as a pivotal moment: it offers the backing to fund Phase II/III efforts while elevating MediLink's corporate profile. For banks, it reinforces Hong Kong's appeal as a biotech capital market when compared with established centres like Nasdaq. With its IPO process underway, MediLink now awaits market timing and regulatory clearances before formally filing a prospectus. The company is expected to continue advancing clinical data, strengthening licensing ties, and preparing investor materials aligned with regulatory requirements.
